TG Therapeutics, Inc. (TGTX)
Company Info
| ISIN | US88322Q1085 |
|---|---|
| CUSIP | 88322Q108 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $2.17B |
|---|---|
| EPS | -$0.19 |
| Revenue (TTM) | $189.77M |
| Gross Profit (TTM) | $2.52M |
| EBITDA (TTM) | -$18.70M |
| Year Range | $6.46 - $35.67 |
| Target Price | $26.83 |
| Short % | 29.77% |
| Short Ratio | 4.52 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in TG Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: TGTX vs. QQQ, TGTX vs. QQQM
Return
TG Therapeutics, Inc. had a return of 39.05% year-to-date (YTD) and 96.54% in the last 12 months. Over the past 10 years, TG Therapeutics, Inc. had an annualized return of 14.78%, outperforming the S&P 500 benchmark which had an annualized return of 9.70%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 39.05% | 18.49% |
| 1 month | 60.49% | 4.20% |
| 6 months | -39.07% | 6.60% |
| 1 year | 96.54% | 15.43% |
| 5 years (annualized) | 26.99% | 11.59% |
| 10 years (annualized) | 14.78% | 9.70% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 7.25% | -6.72% | -16.71% | -49.40% | -20.15% | -7.54% | 65.72% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
TGTX TG Therapeutics, Inc. | 0.99 | ||||
^GSPC S&P 500 | 1.00 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the TG Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the TG Therapeutics, Inc. was 93.19%, occurring on Jun 16, 2022. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.19% | Dec 22, 2020 | 373 | Jun 16, 2022 | — | — | — |
| -81.72% | Mar 20, 2015 | 949 | Dec 24, 2018 | 343 | May 6, 2020 | 1292 |
| -53.86% | Jul 18, 2013 | 87 | Nov 18, 2013 | 71 | Mar 5, 2014 | 158 |
| -40.58% | Mar 17, 2014 | 42 | May 14, 2014 | 20 | Jun 12, 2014 | 62 |
| -33.42% | Jul 7, 2014 | 20 | Aug 1, 2014 | 32 | Sep 17, 2014 | 52 |
Volatility Chart
The current TG Therapeutics, Inc. volatility is 20.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.